Tianmushan Pharmaceutical Overview

  • Year Founded
  • 1958

Year Founded

  • Status
  • Public

  • Employees
  • 392

Employees

  • Stock Symbol
  • 600671

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $2.39
  • (As of Monday Closing)

Tianmushan Pharmaceutical General Information

Description

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China.

Contact Information

Website
www.hztmyy.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Room 1803, Boya Times Building
  • Xiaoshan District
  • Hangzhou, Zhejiang
  • China
+86 0571
Primary Industry
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Room 1803, Boya Times Building
  • Xiaoshan District
  • Hangzhou, Zhejiang
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tianmushan Pharmaceutical Stock Performance

As of 16-Nov-2026, Tianmushan Pharmaceutical’s stock price is $2.39. Its current market cap is $292M with 122M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.39 $2.52 $2.32 - $3.62 $292M 122M 2.98M $0.01

Tianmushan Pharmaceutical Financials Summary

As of 30-Sep-2026, Tianmushan Pharmaceutical has a trailing 12-month revenue of $29.4M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 417,060 328,373 160,814 204,174
Revenue 29,393 29,446 30,283 17,213
EBITDA 2,613 5,829 7,353 (2,011)
Net Income 1,671 2,451 2,125 (5,410)
Total Assets 62,860 63,177 60,474 48,851
Total Debt 23,703 23,762 20,656 16,190
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tianmushan Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tianmushan Pharmaceutical‘s full profile, request access.

Request a free trial

Tianmushan Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tianmushan Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tianmushan Pharmaceutical‘s full profile, request access.

Request a free trial

Tianmushan Pharmaceutical Investments & Acquisitions (4)

Tianmushan Pharmaceutical’s most recent deal was a Merger/Acquisition with Sanshentai Clinic for . The deal was made on 13-Oct-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sanshentai Clinic 13-Oct-2017 Merger/Acquisition Clinics/Outpatient Services
Anhui Dechang Pharmaceutical 27-Jun-2017 Merger/Acquisition Pharmaceuticals
Liaoning Cotech Bio Gen Pharmaceutical 15-Dec-2015 Merger/Acquisition Pharmaceuticals
Huangshan Tianmu Mint Pharmaceutical Company 01-Dec-2006 Joint Venture Pharmaceuticals
To view Tianmushan Pharmaceutical’s complete investments and acquisitions history, request access »

Tianmushan Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Tianmushan Pharmaceutical’s complete esg history, request access »

Tianmushan Pharmaceutical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sanshentai Clinic Hangzhou, China 2014

Tianmushan Pharmaceutical FAQs

  • When was Tianmushan Pharmaceutical founded?

    Tianmushan Pharmaceutical was founded in 1958.

  • Where is Tianmushan Pharmaceutical headquartered?

    Tianmushan Pharmaceutical is headquartered in Hangzhou, China.

  • What is the size of Tianmushan Pharmaceutical?

    Tianmushan Pharmaceutical has 392 total employees.

  • What industry is Tianmushan Pharmaceutical in?

    Tianmushan Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Tianmushan Pharmaceutical a private or public company?

    Tianmushan Pharmaceutical is a Public company.

  • What is Tianmushan Pharmaceutical’s stock symbol?

    The ticker symbol for Tianmushan Pharmaceutical is 600671.

  • What is the current stock price of Tianmushan Pharmaceutical?

    As of 16-Nov-2026 the stock price of Tianmushan Pharmaceutical is $2.39.

  • What is the current market cap of Tianmushan Pharmaceutical?

    The current market capitalization of Tianmushan Pharmaceutical is $292M.

  • What is Tianmushan Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Tianmushan Pharmaceutical is $29.4M.

  • What is Tianmushan Pharmaceutical’s annual earnings per share (EPS)?

    Tianmushan Pharmaceutical’s EPS for 12 months was $0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process